Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-19-000520

Chief Executive Officer sold 5,767 shares at $222.06 ($1,280,632)

  • Chief Executive Officer acquired 5,767 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kummeth Charles R. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-20 Exercise or conversion : show line 1 in the form +5,767 $67.46 $389,042 135,756 D
2019-12-20 Sale : show line 2 in the form −5,767 $222.06 $1,280,632 129,989 D
Open-market sales · 5,767 sh · avg $222.06 · $1,280,632

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-20 Exercise or conversion : show line 3 in the form Stock Options (Right to Buy) −5,767 39,348 D
Loading xslF345X03/edgar.xml…